Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$18.69
0.633.49%
Last update: Oct 2, 5:43 PM
$18.80
0.744.1%
Vor Biopharma Inc (VOR) Stock Price, Quote, News & History
VORNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Vor Biopharma (NASDAQ:VOR) through any online brokerage.
Other companies in Vor Biopharma’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Vor Biopharma has a consensus price target of $61.67.
The stock price for Vor Biopharma (NASDAQ: VOR) is $18.8 last updated October 2, 2026 at 5:43 PM EDT.
There are no upcoming dividends for Vor Biopharma.
Vor Biopharma does not have any upcoming earnings scheduled.
There is no upcoming split for Vor Biopharma.
Vor Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
